DENTSPLY SIRONA (NASDAQ:XRAY) Shares Gap Up Following Insider Buying Activity

DENTSPLY SIRONA Inc. (NASDAQ:XRAY)’s stock price gapped up prior to trading on Tuesday following insider buying activity. The stock had previously closed at $10.14, but opened at $10.50. DENTSPLY SIRONA shares last traded at $10.5150, with a volume of 1,902,937 shares trading hands.

Specifically, Director Brian T. Gladden acquired 9,985 shares of the stock in a transaction dated Monday, June 15th. The shares were bought at an average price of $10.02 per share, with a total value of $100,049.70. Following the purchase, the director directly owned 61,849 shares of the company’s stock, valued at approximately $619,726.98. This trade represents a 19.25% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Brian P. Mckeon bought 10,000 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was acquired at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the acquisition, the director directly owned 10,000 shares in the company, valued at approximately $101,200. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In other DENTSPLY SIRONA news, Director Michael J. Barber bought 15,175 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The stock was acquired at an average cost of $9.88 per share, with a total value of $149,929.00. Following the completion of the purchase, the director directly owned 55,943 shares in the company, valued at approximately $552,716.84. This trade represents a 37.22% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link.

Analyst Ratings Changes

Several research analysts have issued reports on XRAY shares. Citigroup started coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, April 15th. They issued a “sell” rating and a $10.00 price target on the stock. Robert W. Baird increased their price objective on DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a research report on Friday, February 27th. Barclays reduced their price objective on DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a research note on Thursday, June 4th. Bank of America upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $13.00 to $17.00 in a report on Thursday, February 19th. Finally, Wells Fargo & Company boosted their target price on DENTSPLY SIRONA from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $13.55.

DENTSPLY SIRONA Price Performance

The company has a debt-to-equity ratio of 1.52, a current ratio of 1.53 and a quick ratio of 0.98. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of -3.34, a price-to-earnings-growth ratio of 1.20 and a beta of 0.89. The stock’s fifty day moving average price is $10.95 and its 200-day moving average price is $11.71.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The firm had revenue of $880.00 million during the quarter, compared to analyst estimates of $841.80 million. During the same period in the prior year, the business posted $0.43 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently modified their holdings of XRAY. Daiwa Securities Group Inc. grew its holdings in shares of DENTSPLY SIRONA by 2.9% during the fourth quarter. Daiwa Securities Group Inc. now owns 26,814 shares of the medical instruments supplier’s stock valued at $306,000 after buying an additional 767 shares in the last quarter. Blue Trust Inc. boosted its position in DENTSPLY SIRONA by 10.8% during the 1st quarter. Blue Trust Inc. now owns 12,555 shares of the medical instruments supplier’s stock worth $146,000 after acquiring an additional 1,226 shares during the period. Oregon Public Employees Retirement Fund boosted its position in DENTSPLY SIRONA by 3.3% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 40,944 shares of the medical instruments supplier’s stock worth $475,000 after acquiring an additional 1,300 shares during the period. Empowered Funds LLC grew its stake in DENTSPLY SIRONA by 8.8% during the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 1,320 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB grew its stake in DENTSPLY SIRONA by 13.0% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 13,055 shares of the medical instruments supplier’s stock valued at $149,000 after acquiring an additional 1,500 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.